Simon‐Peter Williams

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge et al. · Nature Medicine · 2018 · 734 citations · Full text

Medicine, Oncology, Pharmacology +17

VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain

Nicholas van Bruggen, Harold Thibodeaux, James T. Palmer et al. · Journal of Clinical Investigation · 1999 · 460 citations · Full text

Medicine, Neurobiology, Neuroscience +17

A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function

Frank J. Giordano, Hans‐Peter Gerber, Simon‐Peter Williams et al. · Proceedings of the National Academy of Sciences · 2001 · 370 citations · Full text

Life Sciences, Cardiology, Physiology +17

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

Helen E. Jones, Lindy Goddard, Julia M.W. Gee et al. · Endocrine Related Cancer · 2004 · 298 citations · Full text

Medicine, Oncology, Pharmacology +17

[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease

Sandra Sanabria Bohórquez, Annie Ogasawara, Jeff N. Tinianow et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 130 citations

Life Sciences, Neurology, Neuroscience +13